Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Kellerman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Chest|May 16, 2002
P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearanceDonald J Kellerman
Pain Management|July 26, 2017
Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarrayDonald J Kellerman, Mahmoud Ameri, Stewart J Tepper
Expert Opinion on Investigational Drugs|December 19, 2003
Diquafosol tetrasodium: a novel dry eye therapyKelly K Nichols, Ben Yerxa, Donald J Kellerman
Headache|April 7, 2019
Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future TrialsNada A Hindiyeh, Donald J Kellerman, Peter C Schmidt
Clinical Therapeutics|August 25, 2012
Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteersShashidhar Kori, Donald J Kellerman, Polina Voloshko, et al.
Pain Management|August 6, 2020
Development of a novel zolmitriptan intracutaneous microneedle system (Qtrypta™) for the acute treatment of migraineAlan M Rapoport, Mahmoud Ameri, Hayley Lewis, et al.
Headache|January 31, 2019
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine HeadachesStewart J Tepper, David W Dodick, Peter C Schmidt, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|January 1, 2013
Assessment of the consistency of absorption of dihydroergotamine following oral inhalation: pooled results from four clinical studiesDonald J Kellerman, Amy Forst, Daniel L Combs, et al.
Drug Design, Development and Therapy|August 9, 2013
Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamineRobert J Noveck, Pamela S Douglas, Shein-Chung Chow, et al.
The Journal of Headache and Pain|May 18, 2021
Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraineStephanie J Nahas, Nada Hindiyeh, Deborah I Friedman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Chest|May 16, 2002
P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearanceDonald J Kellerman
Pain Management|July 26, 2017
Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarrayDonald J Kellerman, Mahmoud Ameri, Stewart J Tepper
Expert Opinion on Investigational Drugs|December 19, 2003
Diquafosol tetrasodium: a novel dry eye therapyKelly K Nichols, Ben Yerxa, Donald J Kellerman
Headache|April 7, 2019
Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future TrialsNada A Hindiyeh, Donald J Kellerman, Peter C Schmidt
Clinical Therapeutics|August 25, 2012
Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteersShashidhar Kori, Donald J Kellerman, Polina Voloshko, et al.
Pain Management|August 6, 2020
Development of a novel zolmitriptan intracutaneous microneedle system (Qtrypta™) for the acute treatment of migraineAlan M Rapoport, Mahmoud Ameri, Hayley Lewis, et al.
Headache|January 31, 2019
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine HeadachesStewart J Tepper, David W Dodick, Peter C Schmidt, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|January 1, 2013
Assessment of the consistency of absorption of dihydroergotamine following oral inhalation: pooled results from four clinical studiesDonald J Kellerman, Amy Forst, Daniel L Combs, et al.
Drug Design, Development and Therapy|August 9, 2013
Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamineRobert J Noveck, Pamela S Douglas, Shein-Chung Chow, et al.
The Journal of Headache and Pain|May 18, 2021
Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraineStephanie J Nahas, Nada Hindiyeh, Deborah I Friedman, et al.
Pageof 2